Slavinorm in peripheral arterial atherosclerosis: 78-patient comparison
I. I. Katelnitsky, E. S. Katelnitskaya · 2025 · Cardiology and Cardiovascular Surgery. 18(1):102–108
Reported findings and study design
78 patients: 38 Slavinorm plus baseline care, 40 baseline care plus pentoxifylline. Diabetes excluded; randomization and masking not established.
| Measure | Result | Comparison, timing and statistics |
|---|---|---|
| Ankle–brachial index | Both groups: 0.7→0.8 at two months; at three months active remained 0.8, comparator fell to 0.7. | |
| Walking distance in active group | 22/38 gained 35–40 m; 4/38 unchanged. Remaining improvement range is printed in inverted order; not normalized here. | |
| Harms | Authors report no adverse reactions; ascertainment and longer follow-up remain unresolved. |
The quoted p values in the paper are not all between-arm tests. The comparison does not establish a general vascular or longevity benefit.
Source for the extracted data ↗ · Checked 2026-11-06
Molekul summary of the linked publication. Educational information, not medical advice. Seek qualified healthcare help for medical conditions.
Methods, limitations & source review
Study limitations
- Randomization and masking are not established.
- Comparator percentages do not consistently translate into integer counts out of 40.
- Short-term surrogate and walking outcomes do not establish fewer amputations or cardiovascular events.
Publication counts are not counts of independent trials. Reviews, translations and reports sharing participants may overlap. Findings apply to the studied preparation, population and endpoints.
Document format: Original publisher HTML
Review depth: Methods and selected results narrative checked
Source access and review scope
Original HTML methods, results and references; no independent reanalysis.
Recorded source-check date: 2026-11-06. This date does not imply a completed systematic review.
Source type: Original clinical journal publication
Citation and original source
Original source: I. I. Katelnitsky, E. S. Katelnitskaya. Slavinorm in peripheral arterial atherosclerosis: 78-patient comparison Cardiology and Cardiovascular Surgery. 18(1):102–108 2025.
Molekul research summary: https://molekul.io/research/slavinorm-peripheral-2025. Cite the original publication for its findings and this page when referring to Molekul’s summary or evidence appraisal.
Bibliography entry